Discover investment opportunities in AI Stocks Under 3 Dollar using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Stocks Under 3 Dollar using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Stocks Under 3 Dollar using our Smart AI Filter.
7 stocks found for "AI Stocks Under 3 Dollar"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.98 Risk measure | ±100.0% Price volatility | -0.4 Valuation | 0.00% Annual yield | |||
0.95 Risk measure | ±100.0% Price volatility | -495.0 Valuation | 0.00% Annual yield | |||
0.27 Risk measure | ±100.0% Price volatility | — Valuation | 0.00% Annual yield | |||
1.22 Risk measure | ±88.8% Price volatility | -4.8 Valuation | 0.00% Annual yield | |||
0.79 Risk measure | ±100.0% Price volatility | -28.5 Valuation | 0.00% Annual yield | |||
0.49 Risk measure | ±100.0% Price volatility | -17.8 Valuation | 0.00% Annual yield | |||
1.55 Risk measure | ±100.0% Price volatility | -7.7 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How does Ideanomics (IDEX) integrate sustainability into its business model?
A: Ideanomics (IDEX) focuses on sustainability by promoting electric vehicle (EV) adoption through its Mobility Division. It provides EV financing, charging solutions, and consulting. The company's focus on green technologies aligns with growing ESG investment trends, offering potential appeal to investors prioritizing environmental impact.
Q: What are the potential growth opportunities for SoundHound AI (SOUN)?
A: SoundHound AI (SOUN) could see growth through its voice AI technology, which serves automotive, smart speaker, and IoT sectors. As demand for voice-enabled devices and AI solutions rises, SoundHound AI may benefit from expanded adoption and partnerships within these rapidly growing industries.
Q: What sector is AEye (AEYE) a part of, and why does it matter to investors?
A: AEye (AEYE) operates in the automotive Lidar space, significant for its potential role in autonomous driving. As the self-driving vehicle market grows, companies in this sector may witness increased demand and investment due to their critical technology in navigating autonomous capabilities.
Q: What makes Rekor Systems (REKR) a company to watch in public safety?
A: Rekor Systems (REKR) specializes in AI-based vehicle recognition systems. Its technology supports law enforcement and smart city initiatives. Rising emphasis on public safety and data-driven decision-making could drive demand for REKR's innovative traffic management solutions.
Q: Why might Nerdy Inc. (NRDY) appeal to the education sector?
A: Nerdy Inc. (NRDY) offers an online learning platform that capitalizes on the e-learning boom. The shift towards digital education, accelerated by the pandemic, makes NRDY's offerings attractive for educational institutions seeking scalable, tech-driven solutions for virtual learning environments.
Q: What distinguishes LTRN's focus in the biotech industry?
A: Lantern Pharma (LTRN) leverages AI to accelerate drug discovery and development in oncology. This innovative approach aims to reduce costs and increase the efficacy of cancer therapies, aligning with a growing trend toward personalized medicine within the biotech sector.